Sign in

CIK 0001401667 · Accelerated filer<br>Smaller reporting company

PUMA BIOTECHNOLOGY, INC.

Sign in to watch
Ticker
PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770683487
Phone
(424) 248-6500
Business address
10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
Former names
INNOVATIVE ACQUISITIONS CORP
  1. 4 Planned sale Director sold 27,000 shares at $3.33 ($89,902)
  2. 4 Planned sale Director sold 9,900 shares at $3.39 ($33,528)
  3. 4 Planned sale Director sold 27,000 shares at $3.33 ($89,818)
  4. 4 Planned sale Director sold 22,000 shares at $3.34 ($73,467)
  5. 4 Planned sale Director sold 11,000 shares at $3.37 ($37,096)
  6. 4 Grant or award President and CEO acquired 6,577 shares (grant or award)
  7. 4 Grant or award Chief Scientific Officer acquired 43,307 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 43,307 shares (grant or award)
  9. 4 Grant or award Chief Commercial Officer acquired 27,067 shares (grant or award)
  10. 4 Grant or award President and CEO acquired 160,796 shares (grant or award)
  11. 4 Grant or award See Remarks acquired 37,894 shares (grant or award)
  12. 4 Planned sale Chief Scientific Officer sold 280 shares at $3.76 ($1,053)
  13. 4 Planned sale Chief Scientific Officer sold 7,733 shares at $4.49 ($34,689)
  14. 4 Planned sale Chief Commercial Officer sold 12,956 shares at $4.49 ($58,119)
  15. 4 Planned sale President and CEO sold 41,396 shares at $4.49 ($185,698)
  16. 4 Planned sale Chief Financial Officer sold 15,682 shares at $4.49 ($70,348)
  17. 4 Planned sale See Remarks sold 8,358 shares at $4.49 ($37,493)
  18. 4 Open-market sale Director sold 25,000 shares at $2.83 ($70,803)
  19. 4 Planned sale Chief Scientific Officer sold 6,938 shares at $3.31 ($22,973)
  20. 4 Planned sale Chief Financial Officer sold 14,680 shares at $3.31 ($48,608)

Page 4 of 24 · 471 filings